CDC37 and cancer: These natural compounds utilize a multi-targeted approach through their unique mechanism of action: inducing an oxidative stress response (via generation of reactive oxygen species following metabolism of the epoxide on the B-ring of the molecule) in cancer cells coupled with a novel means of inhibiting HSP90 chaperone function through blockade of Cdc37 docking.